Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating efficacy, safety, and tolerability of mirabegron in older adults with overactive bladder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Overactive Bladder (OAB) | Phase 4 | Status: COMPLETED | Results posted: 2019-02-15